Epidemiological evidence has shown that high circulating IGF-1 levels are positively associated with BC risk (Endogenous Hormones and Breast Cancer Collaborative Group et al. 2010) and prognosis (Murphy et al. 2020; Pasanisi et al. 2008). The gene discussed is IGF1; the disease is breast cancer.